Not all spinning episodes can be resolved with oral steroids. They can be used under a limited number of circumstances, particularly where a clinician has a suspected inflammatory inner ear disease like vestibular neuritis or where vertigo is observed in combination with sudden sensorineural hearing loss. However, when it comes to the most common positional vertigo, maneuvers and vestibular rehabilitation are more important. Vertigo is not a diagnosis but a symptom. A room-spinning sensation can be caused by benign paroxysmal positional vertigo, vestibular neuritis, Ménière's disease, vestibular migraine, and stroke. But they are treated very differently.
Oral steroids are most often recommended due to acute vestibular neuritis, a condition that leads to sudden, persistent vertigo, nausea, imbalance, and nystagmus and may last days instead of seconds. Methylprednisolone initiated within three days enhances recovery in the vestibular tests, but the benefit is not dramatic and might not obviously translate into patient-reported dizziness. According to the primary care advice, steroids have no established part in the normal treatment of vestibular neuritis.
|
Condition |
Are oral steroids central to treatment? |
|
BPPV |
Usually no; repositioning maneuvers are the key treatment |
|
Vestibular neuritis |
Sometimes considered early, but evidence is mixed |
|
Sudden hearing loss with vertigo |
Often urgent ENT care and steroids are commonly used for the hearing-loss component |
|
Ménière’s disease |
Not routine first-line systemic therapy; evidence is limited |
This is why oral steroids, in case of their prescription to treat vertigo, should be regarded as a tool of selection. It is due to the central compensation that many clinicians concentrate on symptom management during the initial day or two followed by vestibular rehabilitation. Sometimes overmedication is counterproductive to that process.
In benign paroxysmal positional vertigo, the best option is a canalith repositioning procedure like the Epley maneuver. Vestibular suppressants should not be a regular treatment of BPPV, and neither should systemic steroids, since the issue lies in mechanical factors: the loose inner-ear particles are not where they belong. Crystals are not repositioned by pills.
Prior to considering medication:
The simple truth is that the positive aspect is disease-specific and the negative is systemic. A short course can be considered a feasible option in some instances, but not a harmless one.
|
Potential upside |
Important limit |
|
May reduce inner-ear inflammation in selected cases |
Does not fix BPPV |
|
May improve vestibular test recovery in some vestibular neuritis studies |
Symptom improvement is less certain |
|
Can be part of urgent treatment when sudden hearing loss is present |
Carries whole-body side effects |
Even short-term oral steroid therapy can increase blood sugar and blood pressure and may produce mood swings or sleep problems. Even more, there are more risks of sepsis, venous thromboembolism, and fracture occurring on short courses, although the risk of any one individual is not very high. It suggests that risk-benefit discourse is more important in patients who have diabetes, are at risk of infection, or have a recent history of clotting or bone fragility.
The right diagnosis and the right physical treatment are the most valuable treatments for many patients. Recent recommendations support canalith repositioning to treat BPPV and vestibular rehabilitation to treat most peripheral vesitibular disorders, such as recovery of vestibular neuritis. Consider:
Among the most serious errors is symptom relief to delay evaluation. The picture changes with new hearing asymmetry, ongoing worsening symptoms, severe gait inability, or any acute neurologic manifestations. The same applies to vertigo that is accompanied by a sudden hearing loss: NIDCD points out that corticosteroids are the most frequently used in sudden deafness cases, and to be more effective, the sooner they are administered, the less chance they have of being reversed the longer the delay between the moment of hearing loss and treatment.
Oral steroids to counter vertigo only make sense when diagnosed. When utilized properly, they might be included in a strategic plan. Their use can be a distraction to the more important maneuver, rehab program, ENT evaluation, or emergency workup.
No. They do not treat vertigo as a symptom in general. They are used in the treatment of selected inflammatory or hearing-related inner-ear disorders but are not used as a standard treatment of BPPV or as a routine treatment of all cases of vestibular neuritis.
Not for BPPV. Whereas, in positional vertigo, the Epley maneuver and other repositioning maneuvers work to eliminate the cause, systemic medication does not.
In case of sudden hearing loss and vertigo, early ENT assessment is necessary since steroids are usually used in sudden deafness and are most effective when initiated early.
Even short courses of steroids may lead to hyperglycemia, blood pressure increase, mood and sleep alterations, and small yet significant short-term risks like infection, clotting, and fracture.